通过法律意见及咨询评估您的知识产权资产
我们每年提供数百条法律意见,从针对具体专利的单一意见,到提供关于复杂专利组合或诉讼的长期、持续咨询服务。我们为客户解决专利有效性、可执行性、滥用、回避设计、许可潜力、知识产权合同构建和执行、以及出口管制等问题。我们定期与客户的法律、业务和技术人员合作,确认从创意产生到专利组合开始盈利整个过程中的潜在风险和收益。
除交易咨询服务外,我们还长期向客户提供诉讼前策略建议。我们拥有丰富的诉讼经验,能够直接洞察诉讼对手可能提出的各种论据。凭借诉讼和知识产权交易的双重经验,我们能够帮助客户在诉讼前或诉讼中有利解决纠纷。
Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products.
Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias.
Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers.
Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer.
Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia.
Advised a biotechnology company on patents covering a well-known biologic medicine for treating eye diseases.
Federal Circuit IP Blog
April 15, 2026
Federal Circuit IP Blog
Federal Circuit Reverses Indefiniteness Ruling on Means-Plus-Function Claim
April 15, 2026
Webinar
January 11, 2024
Webinar
Commentary
How I Made Partner: Finnegan's Danielle Duszczyszyn Shares Six Keys to Business Development Success
December 16, 2020
Charles T. Collins-Chase
Esther H. Lim Nominated as Candidate for President-Elect of the D.C. Bar
March 6, 2017
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.